Cargando…
Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021
A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April–May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel were included. Results showed that an estimated 32.6% of the population in Sweden had detectable levels of antibodies, and am...
Autores principales: | Beser, Jessica, Galanis, Ilias, Enkirch, Theresa, Kühlmann Berenzon, Sharon, van Straten, Edward, Duracz, Jan, Rapp, Marie, Zakikhany, Katherina, Mansjö, Mikael, Wigren Byström, Julia, Forsell, Mattias N. E., Groenheit, Ramona, Tegmark Wisell, Karin, Bråve, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233662/ https://www.ncbi.nlm.nih.gov/pubmed/35752708 http://dx.doi.org/10.1038/s41598-022-15183-w |
Ejemplares similares
-
Point prevalence of SARS-CoV-2 infection in Sweden at six time points during 2020
por: Groenheit, Ramona, et al.
Publicado: (2022) -
High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022
por: Groenheit, Ramona, et al.
Publicado: (2023) -
The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023
por: Anthony, Richard, et al.
Publicado: (2023) -
An outbreak investigation of Legionella non-pneumophila Legionnaires’ disease in Sweden, April to August 2018: Gardening and use of commercial bagged soil associated with infections
por: Löf, Emma, et al.
Publicado: (2021) -
Rapid emergence of omicron sublineages expressing spike protein R346T
por: Groenheit, Ramona, et al.
Publicado: (2022)